779600login-checkMaintenance Immunosuppressive Drugs Tied to Severe COVID-19 |
Findings seen for recipients across solid organ transplant types
By Lori Solomon
(HealthDay News) — Maintenance immunosuppressive drugs are associated with an increased risk for COVID-19 hospitalization in solid organ transplant recipients, according to a study published online Nov. 7 in JAMA Network Open. Read the article in HealthDay.
779600login-checkMaintenance Immunosuppressive Drugs Tied to Severe COVID-19 |
If you get a Moderna vaccine every 3
Months, eventually you will get humoral but NOT T-Cell immunity.
If & when Astra Zenica gets approval for their new PEGylated MAb, get it. It lasts 6 months. Their prior vaccine called “Evusheld” was withdrawn from market last year since it was NOT protective against any of the recent Omicron strains. Their new MAb is called “SUPERNOVA” I think, but not yet available; hopefully in 2024 or 2025. Hopefully. B4 COVID mutates so much the FDA refuses to approve. There is Plaxovid, but immunosuppressed folk shouldn’t take it!